- Home
- AUTL vs SES Comparison
AUTL vs SES Comparison
Compare AUTL & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | SES |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United Kingdom | United States |
| Employees | N/A | 215 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.2M | 384.1M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | SES |
|---|---|---|
| Price | $1.70 | $1.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $8.50 | $4.00 |
| AVG Volume (30 Days) | 1.6M | ★ 11.7M |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | $53.90 |
| Revenue Next Year | $53.96 | $111.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $0.80 |
| 52 Week High | $2.70 | $3.73 |
Technical Indicators
Market Signals| Indicator | AUTL | SES |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 64.64 |
| Support Level | $1.27 | $0.96 |
| Resistance Level | $1.73 | $1.35 |
| Average True Range (ATR) | 0.13 | 0.10 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 49.03 | 88.64 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About SES SES AI Corporation
SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.